AstraZeneca in China: Opportunities and Challenges [1/2]
AstraZeneca is a British pharmaceutical company founded in 1999 that focuses on discovering, developing, and commercializing prescription medicines in oncology, rare diseases, and biological medicals for cardiovascular, renal, metabolism, respiratory and immunology diseases.
Jul 05, 2022 03:21 PM
ResearchTechnology, Healthcare, Consumer Staples
WIA2020 | Rising Tech Stars 2020: Global & China's 100
AI-driven Pharmaceutical Company Phil Rivers Nets Hundreds of Mns of CNY in Series A Round
Phil Rivers, incubated by the Institute of Computing Technology of the Chinese Academy of Sciences, is a platform company that drives drug discovery with 'computational medicine'.
Yesterday 10:08 PM
Precision Autoimmune Therapeutics Earned CNY 140 Mn in Angel Financing Round
Biotech firm Precision Autoimmune Therapeutics, specializing in the research and development of innovative drugs for autoimmune diseases, will focus on the precise therapies of autoimmune diseases.
Jul 06, 2022 09:53 PM
Anti-cancer Drugs Developer Affinity Completed Series A+ Round
Affinity, a biopharmaceutical company focusing on developing anti-cancer drugs, gained capital favor for its tumor microenvironment activated platform and opportunities it may bring to oncology treatment.
Jul 06, 2022 08:42 PM